Evidence map›Paper›PMID 39823427›Full record

ArticlePloS one2025

Spontaneous oxycodone withdrawal disrupts sleep, diurnal, and electrophysiological dynamics in rats.

Michael Gulledge, William A Carlezon, R Kathryn McHugh, Elizabeth A Kinard, Michael J Prerau, Elena H Chartoff

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Spontaneous daily sleep disruptions associated with morphine dependence and withdrawal in rats.The Journal of pharmacology and experimental therapeutics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michael GulledgeDept. of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, United States of America.
William A CarlezonDept. of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, United States of America.
R Kathryn McHughDept. of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, United States of America.
Elizabeth A KinardDept. of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, United States of America.
Michael J PrerauDivision of Sleep Medicine, Dept. of Medicine, Harvard Medical School, Brigham & Women's Hospital, Boston, Massachusetts, United States of America.
Elena H ChartoffDept. of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, United States of America.ORCID 0000-0002-1657-694X

Funding

Neurobiological mechanisms of prescription opioid withdrawalR01DA045000 · NIDA · MCLEAN HOSPITAL · PI CHARTOFF, ELENA H · 2017 to 2021
$2.1M
Affective and Inflammatory Reactivity to Pain in Opioid Use DisorderR01DA045632 · NIDA · MCLEAN HOSPITAL · PI MCHUGH, REBECCA KATHRYN · 2019 to 2022
$1.5M
Role of lateral hypothalamus projections in opioid withdrawal-induced sleep deficitsR21DA056864 · NIDA · MCLEAN HOSPITAL · PI CARLEZON, WILLIAM A., PRERAU, MICHAEL J · 2022 to 2023
$466k
NIDA NIH HHS R01 DA045000NIDA NIH HHS R01 DA045632NIDA NIH HHS R21 DA056864
6 · The paper itself

Abstract

Opioid dependence is defined by an aversive withdrawal syndrome upon drug cessation that can motivate continued drug-taking, development of opioid use disorder, and precipitate relapse. An understudied but common opioid withdrawal symptom is disrupted sleep, reported as both insomnia and daytime sleepiness. Despite the prevalence and severity of sleep disturbances during opioid withdrawal, there is a gap in our understanding of their interactions. The goal of this study was to establish an in-depth, temporal signature of spontaneous oxycodone withdrawal effects on the diurnal composition of discrete sleep stages and the dynamic spectral properties of the electroencephalogram (EEG) signal in male rats. We continuously recorded EEG and electromyography (EMG) signals for 8 d of spontaneous withdrawal after a 14-d escalating-dose oxycodone regimen (0.5-8.0 mg/kg, 2×d; SC). During withdrawal, there was a profound loss (peaking on days 2-3) and gradual return of diurnal structure in sleep, body temperature, and locomotor activity, as well as decreased sleep and wake bout durations dependent on lights on/off. Withdrawal was associated with significant alterations in the slope of the aperiodic 1/f component of the EEG power spectrum, an established biomarker of arousal level. Early in withdrawal, NREM exhibited an acute flattening and return to baseline of both low (1-4 Hz) and high (15-50 Hz) frequency components of the 1/f spectrum. These findings suggest temporally dependent withdrawal effects on sleep, reflecting the complex way in which the allostatic forces of opioid withdrawal impinge upon sleep and diurnal processes. These foundational data based on continuous tracking of vigilance state, sleep stage composition, and spectral EEG properties provide a detailed construct with which to form and test hypotheses on the mechanisms of opioid-sleep interactions.

Indexed as

Analgesics, OpioidCircadian RhythmOxycodoneSleepSubstance Withdrawal SyndromeAnimalsElectroencephalographyElectromyographyMaleOpioid-Related DisordersRatsRats, Sprague-DawleyAnalgesics, OpioidOxycodone

Identifiers

PMID39823427
PMCPMC11741586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.